Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Pfizer Inc.
IndexDJIA S&P500 P/E20.22 EPS (ttm)1.58 Insider Own0.02% Shs Outstand6.30B Perf Week3.20%
Market Cap201.24B Forward P/E14.36 EPS next Y2.23 Insider Trans-4.76% Shs Float6.30B Perf Month4.93%
Income10.46B PEG14.97 EPS next Q0.53 Inst Own72.10% Short Float1.04% Perf Quarter6.75%
Sales50.05B P/S4.02 EPS this Y37.50% Inst Trans-0.55% Short Ratio2.51 Perf Half Y10.37%
Book/sh12.32 P/B2.59 EPS next Y-1.02% ROA18.70% Target Price34.19 Perf Year7.65%
Cash/sh5.31 P/C6.02 EPS next 5Y1.35% ROE41.80% 52W Range27.27 - 33.12 Perf YTD7.94%
Dividend1.04 P/FCF22.16 EPS past 5Y6.80% ROI10.50% 52W High-3.56% Beta0.68
Dividend %3.26% Quick Ratio2.50 Sales past 5Y1.30% Gross Margin80.90% 52W Low17.12% ATR0.60
Employees77700 Current Ratio2.90 Sales Q/Q-2.20% Oper. Margin32.90% RSI (14)66.83 Volatility2.08% 1.88%
OptionableYes Debt/Eq0.48 EPS Q/Q7.70% Profit Margin64.40% Rel Volume1.70 Prev Close31.97
ShortableYes LT Debt/Eq0.41 EarningsOct 28 BMO Payout21.10% Avg Volume26.00M Price31.94
Recom2.20 SMA202.20% SMA506.31% SMA2007.74% Volume44,141,724 Change-0.09%
Dec-18-14Reiterated Deutsche Bank Buy $34 → $35
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Jan-22-13Reiterated Barclays Equal Weight $24 → $25
Nov-27-12Downgrade MKM Partners Buy → Neutral $29 → $25
Oct-05-12Reiterated MKM Partners Buy $27 → $29
Nov-01-11Downgrade Standpoint Research Buy → Hold
Oct-07-11Initiated MKM Partners Buy $20.50
Sep-14-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
Aug-10-11Upgrade Argus Hold → Buy $21
Aug-05-11Upgrade Standpoint Research Hold → Buy $21
Mar-14-11Downgrade Standpoint Research Buy → Hold
Nov-03-10Downgrade Argus Buy → Hold
May-21-10Initiated Jefferies Buy $17.80
Dec-16-09Initiated UBS Buy
Apr-27-09Initiated Standpoint Research Buy $20
Feb-12-09Upgrade Leerink Swann Mkt Perform → Outperform
Feb-09-09Upgrade UBS Neutral → Buy
Dec-19-14 05:20PM  United Therapeutics Lung Drug Keeps Going And Going at Investor's Business Daily
Dec-18-14 12:43PM  Midday movers: Microsoft, Rite Aid, Pfizer & more at CNBC
09:13AM  Pfizer Reports Statistically Significant Results for Nerve-Pain Treatment at The Wall Street Journal
08:37AM  Pfizer Partners With Young Little Known Biotech For Products With Huge Potential Value at Forbes
08:00AM  Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia Business Wire
04:58AM  The Greatest Tax Story Ever Told at BusinessWeek
Dec-17-14 08:00AM  Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy Business Wire
12:01AM  Celebrex, VirnetX, Hartz, Hanesbrands: Intellectual Property at Bloomberg
Dec-16-14 11:38AM  Pfizer Ponies Up to Develop Long-acting Growth Hormone at TheStreet
10:00AM  Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts Business Wire
08:00AM  Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis Business Wire
Dec-15-14 06:30PM  Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology Business Wire
02:10PM  Business events scheduled for Tuesday AP
01:50PM  Pfizer, OPKO Health partner on growth-hormone treatment at MarketWatch
12:41PM  Pfizer, OPKO Health Partner on Growth-Hormone Treatment at The Wall Street Journal
12:08PM  Taking oil issue to far, be rational: Strategist CNBC
12:06PM  Pfizer Declares First-Quarter 2015 Dividend Business Wire
12:01PM  Pfizer Licenses Opko's Long-Acting Growth Hormone at Investor's Business Daily
10:13AM  Bank Of America's Top 10 Stocks For 2015 Benzinga
09:34AM  Biotech Entrepreneur Tony Coles Takes Aim At Parkinson's And Alzheimer's at Forbes
08:48AM  Opko Health Soars 13% On Pfizer hGh-CTP News Benzinga
08:00AM  OPKO and Pfizer Enter into Global Agreement for OPKOs Long-Acting Human Growth Hormone (hGH-CTP) Business Wire
Dec-12-14 10:14PM  Nestlé Chief Paul Bulcke Takes a Global View at
10:22AM  MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day Zacks
Dec-11-14 02:28PM  How Can Digital Health Startups Work With Health Insurers And Big Pharma? at Forbes
09:57AM  FDA warns Pfizer's antipsychotic could cause fatal skin reaction Reuters
Dec-10-14 04:23PM  Moody's Affirms Four and Downgrades Two Classes of GSMS 2007-GG10 at Moody's
12:49PM  Midday movers: Lands' End, Wynn Resorts, Exxon & more at CNBC
12:41PM  Drug makers face another $65 billion patent cliff at MarketWatch
10:35AM  What a Generic Celebrex Means for Pfizer and for Actavis at 24/7 Wall St.
10:22AM  6 ugly stocks that look sexy in 2015 at
09:25AM  Trading Biotechs From His Bedroom Nate Pile Beats The Street at Forbes
09:00AM  Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause Business Wire
08:28AM  GSK Changes Its Drug Sales Practices And R&D Suffers at Forbes
05:13AM  StanChart sets up financial crime committee after U.S. scrutiny extension Reuters
Dec-09-14 10:30AM  New Data at ASH 2014 Highlight Progress of Pfizers Growing Portfolio in Blood Cancers Business Wire
Dec-08-14 04:32PM  Missouri's Koster denies lobbyist influence AP
02:07PM  From AARP To Pfizer, Partners Seek Optum Labs Big Data To Improve Health at Forbes
01:30PM  Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects Business Wire
11:48AM  Merck Acquiring Cubist, Focusing On Hospital Care at Investor's Business Daily
09:48AM  Pfizer bets on gene therapy as technology comes of age Reuters
08:00AM  Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform Business Wire
Dec-05-14 12:00AM  Sky-High Genetic Cholesterol Targeted for Blockbuster Drug. Now Just Find the Patients Bloomberg
Dec-04-14 04:47PM  Hot Drugmakers Build More Labs, Grab Space In Boston Investor's Business Daily
04:47PM  Hot Drugmakers Build More Labs, Grab Space In Boston at Investor's Business Daily
11:29AM  Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative PR Newswire
10:00AM  Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative PR Newswire
Dec-03-14 05:07PM  Phase 3 Results Published in The New England Journal of Medicine Show Superiority of Pfizers XALKORI® (crizotinib) Compared to Platinum-Based Chemotherapy in Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Canc Business Wire
03:14PM  Guess whos opposed to corporate tax reform: Corporations Yahoo Finance
12:11PM  WADA signs deal with US-based drug maker AP
11:43AM  Puma Biotech Stock Plunges On Drug Filing Delay at Investor's Business Daily
11:26AM  AstraZeneca Fights Billions in Possible Nexium Damages Bloomberg
11:00AM  Alzheimer's drug shows promise CNBC
Dec-02-14 05:58PM  Your first trade tomorrow: CP, ABT, BBRY & F CNBC
05:22PM  Unusual Activity: Abbott Labs CNBC
05:18PM  Early Tests Go Well For Biogen's Drug To Slow Alzheimer's Investor's Business Daily
05:14PM  Alexandria Real Estate REIT Inks Rx For Pharma Boom at Investor's Business Daily
12:58PM  FMHR Final Trade: PFE, RVBD, DE & TOL CNBC
12:23PM  Biogen Alzheimer's Drug Succeeding In Early Tests at Investor's Business Daily
08:33AM  The Debate Over The Cost To Develop A New Drug at Forbes
08:00AM  New Survey Finds Majority of Women with Breast Cancer Who Work Want to Do So Even While Undergoing Treatment Business Wire
Dec-01-14 03:08PM  Pfizer closes $635M vaccines purchase from Baxter AP
11:36AM  Jim Cramer on the Stock Market: Here Are 12 Sectors to Bet On at TheStreet
07:30AM  Pfizer Completes Acquisition of Baxters Marketed Vaccines Business Wire
Nov-28-14 02:45AM  I'm a strong believer in Europe: Astrazeneca CEO CNBC
02:45AM  Drug pipeline strong, less need for M&A: Astrazeneca CEO CNBC
02:30AM  Astrazeneca could eye tech firms for M&A: Expert CNBC
01:05AM  Pfizer deal would have failed: Astrazeneca CEO CNBC
01:01AM  Pfizer deal probably 'would have fallen apart': AZ CEO at CNBC
Nov-26-14 03:40PM  Intra-Cellular Commences Phase III Schizophrenia Study Zacks
06:00AM  These 5 Big Dividend Stocks Want to Pay You More: Pfizer, Coke and More at TheStreet
04:35AM  Pfizer to join forces with AstraZeneca? CNBC
03:34AM  Back for more: Will Pfizer top its AstraZeneca bid? at CNBC
01:20AM  Pfizer to renew pursuit of AstraZeneca? CNBC
Nov-25-14 09:02AM  AstraZeneca comes into focus as Pfizer's cooling-off period ends at Financial Times
Nov-24-14 10:57AM  Buying Glaxo's Biotech Stock Throwbacks Proves Profitable Yahoo Finance Blogs
Nov-22-14 05:00AM  Motley Fool: Pundits pandering your wealth away at USA TODAY
Nov-21-14 08:13AM  Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug? at Forbes
Nov-20-14 12:19PM  Apple, Pfizer, GM and other financial turkeys of 2014 at Fortune
Nov-19-14 02:35PM  Will The IMPROVE-IT Results Impact The Thinking Of The FDA And Payers On LDL-Cholesterol Lowering Drugs? at Forbes
11:07AM  Stocks Boosted by Merck's Vytorin Data at
Nov-18-14 05:15PM  Merck KGaA Ties Up with Pfizer on Immuno-oncology Deal Zacks
12:23PM  AstraZeneca fleshes out standalone strategy at Financial Times
11:54AM  AstraZenecas Soriot Asks for Patience as Pfizer Return Looms at Bloomberg
09:38AM  AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer Reuters
08:30AM  TRUMENBA® (Meningococcal Group B Vaccine) is Now Available Business Wire
07:15AM  Are consumers getting gouged on health-care? at MarketWatch
03:44AM  Neil Woodford says belief in independent AstraZeneca "even stronger" Reuters
02:20AM  AstraZeneca trumpets progress in cancer, other drugs Reuters
Nov-17-14 05:16PM  Allergan Sides With More Aggressive Dealmaker By Picking Actavis Over Valeant at Forbes
04:56PM  The Top Ten Stocks for Nov. 17 at Bloomberg
04:00PM  Stocks little moved; S&P 500 at record-high close at CNBC
03:51PM  US, German drugmakers team up on cancer medicines AP
02:04PM  Will Lower Guidance Hurt Pfizer (PFE) Stock Today? at TheStreet
01:35PM  Merck Drug Works: Vytorin Study Proves Successful at Investor's Business Daily
12:35PM  Zoetis attractive & durable: Pro CNBC
11:47AM  Cramer: Pfizer Deal With Merck Leaves AstraZeneca in the Cold at TheStreet
11:05AM  Pfizer, Germanys Merck strike deal to develop cancer tumor treatment at MarketWatch
10:40AM  Allergan Agrees To $219 A Share Actavis Takeover Over Bill Ackman-Backed Valeant Deal at Forbes
10:23AM  [video]Pfizer Is Set to Buy Merck Cancer Drug Rights for $850 Million at TheStreet
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd.; and strategic collaboration with iTeos Therapeutics SA. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MADDALUNA ANTHONY JExecutive Vice PresidentDec 08Sale32.006,500208,00082,830Dec 09 10:44 AM
HILL CHARLES HExecutive Vice PresidentNov 10Sale30.188,285250,04199,478Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Option Exercise26.2021,600565,920123,462Nov 10 05:34 PM
DAMELIO FRANK AExecutive Vice PresidentNov 07Sale29.7807454,687Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Sale29.8921,600645,548101,862Nov 10 05:34 PM
READ IAN CChairman & CEOOct 30Option Exercise17.0354,585929,5831,465,906Nov 03 06:23 PM
DAMELIO FRANK AExecutive Vice PresidentOct 30Option Exercise17.0365,5021,115,499501,494Nov 03 06:23 PM
READ IAN CChairman & CEOOct 30Sale29.7667,5002,008,8001,358,862Nov 03 06:23 PM
MADDALUNA ANTHONY JExecutive Vice PresidentOct 29Sale29.562,42571,68388,987Oct 30 06:23 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Option Exercise26.2036,275950,40593,010Jun 13 12:29 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Sale29.5336,2751,071,27856,735Jun 13 12:29 PM
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.82131,8104,062,225356,451Jan 14 07:13 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.8628,190869,817328,261Jan 14 07:13 PM